Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeOur CompanyAWP Decision
      Our Company

      AWP Decision

      Share Article
      share to

      Earlier today, Judge Patti B. Saris of the US District Court for Massachusetts issued her decision in a case examining the pricing of pharmaceutical drugs reimbursed by Medicare and private insurers based on what’s known as the average wholesale price, or AWP. In the case, the plaintiffs alleged that four pharmaceutical companies including Johnson & Johnson (actually our Centocor and Ortho Biotech companies) engaged in unfair and deceptive trade practices in violation of Massachusetts laws, and grossly inflated the AWPs of certain drugs.

      The judge dismissed the case against the Johnson & Johnson defendants.

      The opinion is 185 pages long - and I understand our lawyers are still studying it. I can tell you that we are pleased with the judge’s finding of no liability for the Johnson & Johnson companies involved and with her ruling in their favor.

      Some initial coverage here and here.

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.